NK cells express multiple activating receptors such as CD16, also known as FcγRIIIA, NKG2D, NKp30, NKp44 and NKp46 cytotoxicity receptors, all of which could be used to trigger anti-tumor immunity (75). This evidence concerns the gene KLRK1 and neoplasm.